RBGPF
-0.2700
Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain™, Medical Drones and Health Lives Here progressRecent capital raise provides capital into late 2026, including meeting criteria for DelivMeds AI transaction funding closing conditionRecent capital raise and debt restructuring preclude the Company from issuing shares for capital raising purposes until the earlier of seven (7) months from the transaction date and thirty (30) days after effectiveness of the resale registration statement covering the underlying securities.Recent lock-up agreement to limit shares available for sale into the marketExercise of warrants embedded in recent financing would provide funding through 2029
NEWARK, CA / ACCESS Newswire / June 1, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that four abstracts highlighting rusfertide in polycythemia vera (PV) will be presented at the 2026 European Hematology Association Congress (EHA2026 Congress), taking place June 11-14, 2026, in Stockholm, Sweden. The presentations include analyses from the randomized, controlled Phase 3 VERIFY study, as well as long-term results from the Phase 2 REVIVE and THRIVE open-label extension studies.
The Best Mommy Makeover In Seattle Is By Dr. Javad Sajan
Coalition for Epidemic Preparedness Innovations funding builds on Moderna's prior filovirus research and supports preclinical development and Phase 1 clinical evaluation
The French capital laid out a red, white and blue carpet Sunday for Paris Saint-Germain players to mark their second straight Champions League title, amid bitter recriminations after hundreds of people were arrested and dozens of police hurt in a night of unrest.
The French capital laid on a hero's welcome Sunday for Paris Saint-Germain players to mark their second straight Champions League title, amid bitter recriminations after hundreds of people were arrested and dozens of police hurt in a night of unrest across the country.
Paris prepared a hero's welcome for Paris Saint-Germain players who won their second consecutive Champions League title with celebrations planned in the capital under heavy security after a night of revelry marred by unrest.
Harwati clasped her hands and offered a prayer on the edge of a sludge lake on the Indonesian island of Java, as dozen of residents gathered to mark two decades since mud volcano eruptions began displacing thousands.
Australian researchers have trained lab-grown brain cells on a silicon computer chip to play the nineties shooter "Doom" and say they are just scratching the surface of what the neurons could be capable of doing.
Claw machine lover Neiki Lee carefully lowers the metal jaws of a crane with a joystick into a pool of prizes, only to have the small toy slip from its clutches again and again.
The Trump administration has walked back its announcement that non-citizens seeking permanent US residency, commonly called a Green Card, would need to return to their home country to apply, The New York Times reported.
A damp towel hangs from a barred window, a fan churns the muggy air: Inmates at the overcrowded Villepinte prison outside Paris say enduring a heatwave that has stifled France in recent days in cramped cells is "inhumane".
The Canadian man who sold poison to distressed people worldwide pleaded guilty on Friday to 14 counts of aiding suicide but avoided a murder trial, an outcome one victim's father branded "a disgrace."
The Canadian man who helped scores of people worldwide kill themselves by selling them poison pleaded guilty on Friday to 14 counts of aiding suicide, as prosecutors said they will withdraw murder charges.
A former German transport minister faces a perjury trial related to a failed scheme to charge foreign motorists highway tolls, a debacle that cost the government hundreds of millions of euros.
Blue Origin's New Glenn rocket exploded during a test Thursday on the launch pad in Cape Canaveral, Florida, though officials said no injuries were reported from the incident.
Company accelerates evolution into AI-powered platform transforming how boats are bought and sold
NHRA Potomac Nationals Provide a Powerful Platform for American Rebel Light Beer's Nationwide Expansion Strategy and Multi-Class Racing PresenceMulti-Class NHRA Platform Delivers Coast-to-Coast Broadcast Reach and Trackside Impact for American Rebel Light - America's Patriotic Beer BrandAmerican Rebel-Branded Sponsorship with Tony Stewart Racing, Matt Hagan, Leah Pruett, and John Hall Amplifies National Brand Momentum Across FOX, FS1, and NHRA.tv While Connecting with NHRA's Loyal, Values-Driven Fan Base
The United States on Thursday designated two well-known Brazilian crime groups, the so-called Red Command (CV) and First Capital Command (PCC), as terrorist organizations, despite opposition from Brasilia.
Netflix and other streaming services on Thursday criticised a German plan requiring platforms to reinvest a share of locally generated revenue as part of efforts to support domestic film production.
A man reportedly shouting "Allahu akbar!" injured three people with a bladed weapon at a train station near Zurich on Thursday, before being arrested, Swiss police said.
Lawmakers were moved to tears in parliament Thursday as France inched towards repealing outdated legislation that defines people enslaved in its colonies as "moveable goods", in a symbolic move as the country grapples with its colonial legacy.
Italy said Thursday it was seizing more than 200 million euros ($232 million) in assets belonging to late Mafia boss Matteo Messina Denaro derived from drug trafficking and reinvested in Europe and beyond.
The EU slapped a 200-million-euro ($232 million) fine on Chinese-owned online retailer Temu on Thursday for allowing the sale of illegal products, including dangerous baby toys and defective chargers.
American Rebel Holdings (OTC:AREB) CEO Andy Ross took America's Patriotic Brand™ to Dr. Drew's national audience yesterday - discussing the Second Amendment, Stand Your Ground principles, patriotism, and his new Patriotic Anthem celebrating 250 years of America "Hold my Beer", with the full segment now available to watch on replay
Crofelemer delayed-release tablets are Jaguar's FDA-approved prescription drug under botanical guidance ("botanical drug") derived from the Croton lechleri tree. Crofelemer, in a novel liquid formulation, is being developed as the potential first oral adjunctive therapy for Intestinal Failure (IF) from microvillus inclusion disease (MVID) and short bowel syndrome (SBS)Crofelemer development with novel formulations for different gastrointestinal disorders reflects a differentiated botanical drug platform integrating ethnobotanical medicine, sustainable harvesting, complex CMC, and novel bioassays to support approval under FDA botanical guidanceTraditional knowledge of Croton lechleri use supported ethnobotanical research that led to development and approval of crofelemer, whose first in class anti-secretory mechanism was characterized through modern pharmacology and mechanism-based bioassays. Recent milestones include continued evaluation in an extension phase for Jaguar family company Napo's pivotal clinical trial of crofelemer as adjunctive therapy to Parenteral Support (PS) for MVID and upcoming ESPGHAN presentations in pediatric MVID and SBS-IF patientsFDA approval of crofelemer as an oral botanical drug highlights the totality-of-evidence and creates a significant practical barrier to generic replication
Company discusses AI-assisted body-map monitoring architecture and long-term imaging technology development initiatives
AUSTIN, TX / ACCESS Newswire / May 28, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today published an updated investor presentation detailing its acquisition-driven operating strategy, the contribution of recently completed acquisitions, and an increased M&A pipeline.
ESTERO, FL / ACCESS Newswire / May 28, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today issued the following letter to shareholders from Chief Executive Officer Kraig Higginson.
June 2026 event welcomes squadron veterans and families back to Marine Corps Air Station Cherry Point for a once-in-a-generation farewell.
Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement
NEWARK, CA / ACCESS Newswire / May 28, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in two investment bank conferences taking place in June 2026.